Suppr超能文献

AN69透析效率,一种不太适合扩散的半合成膜。

Dialysis Efficiency of AN69, a Semisynthetic Membrane Not Well Suited for Diffusion.

作者信息

Herrera-Gutiérrez M E, Seller-Pérez G, Arias Verdu D, Jironda-Gallegos C, Martín-Velázquez M, Quesada-García G

机构信息

ICU, Carlos Haya Hospital, Carlos Haya Avenue s/n, 29010 Málaga, Spain.

Nephrology, Carlos Haya Hospital, 29010 Málaga, Spain.

出版信息

ISRN Nephrol. 2012 Dec 20;2013:185989. doi: 10.5402/2013/185989. eCollection 2013.

Abstract

AN69 membrane is not suited for diffusion, with an suggested limit at 25 mL/min dialysate flow rate. When prescribing continuous hemodialysis this threshold must be surpassed to achieve. We designed a study aimed to check if a higher dose of dialysis could be delivered efficiently with this membrane. Ten ICU patients under continuous hemodiafiltration with 1.4 m(2) AN69 membrane were included and once a day we set the monitor to exclusively 50 mL/min dialysate flow rate and 250 mL/min blood flow rate and after 15 minutes measured dialysate saturation for urea, creatinine, and β 2-microglobulin. We detected that urea saturation of dialysate was nearly complete (1.1 ± 0.09) for at least 40 hours, while creatinine saturation showed a large dispersion (0.86 ± 0.22) and did not detect any relation for these variables with time, blood flow, or anticoagulation regime. Saturation of β 2-microglobulin was low (0.34 ± 0.1) and decreased discretely with time (r (2) = 0.15, P < 0.05) and significantly with TMP increases (r (2) = 0.31, P < 0.01). In our experience AN69 membrane shows a better diffusive capability than previously acknowledged, covering efficiently the range of standard dosage for continuous therapies. Creatinine is not a good marker of the membrane diffusive capability.

摘要

AN69膜不适合用于扩散,建议的透析液流速上限为25毫升/分钟。在进行持续性血液透析时,必须超过这个阈值才能实现目标。我们设计了一项研究,旨在检查使用这种膜是否能够有效地提供更高剂量的透析。纳入了10例使用1.4平方米AN69膜进行持续性血液滤过的重症监护病房患者,每天一次,我们将监测器设置为仅50毫升/分钟的透析液流速和250毫升/分钟的血流速,15分钟后测量透析液中尿素、肌酐和β2-微球蛋白的饱和度。我们检测到,透析液中尿素饱和度在至少40小时内几乎达到完全饱和(1.1±0.09),而肌酐饱和度差异较大(0.86±0.22),且未发现这些变量与时间、血流或抗凝方案之间存在任何关系。β2-微球蛋白的饱和度较低(0.34±0.1),并随时间逐渐降低(r(2)=0.15,P<0.05),且随跨膜压升高显著降低(r(2)=0.31,P<0.01)。根据我们的经验,AN69膜的扩散能力比之前认为的更好,能够有效地覆盖持续性治疗的标准剂量范围。肌酐不是膜扩散能力的良好标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e104/4045434/fd6a2abf94fc/ISRN.NEPHROLOGY2013-185989.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验